Zero Candida Technologies Inc. (ZCT.V) remains steady as it navigates recent developments.
Zero Candida Technologies Inc. has seen no significant price movement this week, maintaining its last close of C$0.15. The company has been active in its sector but has not released any major news in the past week.
Investor takeaway: Investors should note that while Zero Candida has made strides in innovation and production, the stock's performance remains stagnant amidst ongoing challenges.
Advertisement
Zero Candida Technologies Inc.
ZCT.V
ZCT.V
Zero Candida Technologies Inc.
WealthAwesomeMarket cap
$2.93M
52W high
$0.28
52W low
$0.11
1W change
+0.00%
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ZCT's historical volatility
30-Day Vol
195.9%
Annualized
90-Day Vol
156.1%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.13
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.14 | C$0.07 – C$0.28 |
| 60 trading days | C$0.13 | C$0.05 – C$0.35 |
| 90 trading days | C$0.13 | C$0.04 – C$0.40 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Zero Candida Technologies Inc. Stock Stays Flat at C$0.15
With a market cap of approximately C$2.93 million and a profit margin of 0.0%, the company is still in the early stages of its growth trajectory.
Bull case
The recent patent grant and the scaling of production for the ZC-001 therapeutic device suggest potential for future growth and market interest. This development could attract more attention from investors as the company progresses in its innovation efforts.
Bear case
The stock's year-to-date decline of over 21% raises concerns about the company's operational performance and market perception. Investors may be wary as they consider the implications of this downturn on future growth.
Price Action Overview
Zero Candida Technologies Inc. (ZCT.V) has maintained its last close at C$0.15, with no change in price over the past week. The stock has faced a year-to-date decline of 21.05%, reflecting challenges in market conditions and company performance.
Recent Developments
Advertisement
While there have been no new announcements from Zero Candida this week, the company has previously made headlines with significant developments, including the granting of Patent No. 12654025B2 on June 24, 2026. This patent represents a milestone in their commitment to innovation in women's health technology. Additionally, they announced plans to scale production of their ZC-001 therapeutic device, which is set to support clinical testing later this year.
Technical Picture
The technical indicators for ZCT.V show that the stock is trading at its 50-day moving average of C$0.15, slightly below this average by 1.2%. The 200-day moving average stands at C$0.18, indicating a larger divergence of 14.4%. The stock has a 52-week range of C$0.11 to C$0.28, currently at 24% of its range, suggesting limited volatility. The latest trading volume was 7,000 shares, which is significantly higher than the 20-day average volume of 3,847 shares, indicating increased interest.
Insider Activity
There have been no reported insider transactions for Zero Candida Technologies Inc. in recent weeks.
Conclusion
Zero Candida Technologies Inc. (ZCT.V) remains at a standstill in terms of price action, closing at C$0.15. While the company has made notable strides in innovation and production, investors should consider the broader market context and the implications of the stock's year-to-date performance.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
